Vintervelez6400

The subsequent anisotropic yield behavior of 45 steel was predicted by the distortional yield surface constitutive model, which can describe the anisotropic subsequent yield and the cross effect of metal associating with loading history. (S)-2-Hydroxysuccinic acid price The yield characteristics and plastic hardening behaviors of the 45 steel were simulated under three preloading paths including pre-torsion, pre-tension, and pre-tension-torsion. Based on the comparison between the experimental yield stresses and the simulation by the classical Chaboche model, the proposed model can describe the remarkable anisotropic yield behavior related to the loading history, which can effectively describe the sharp point of yield surface in pre-loading direction and the smaller curvature near its opposite direction. It was successfully simulated by the constitutive model proposed that the subsequent distortional yield surface defined by small offset strain and the degradation process of the distortion feature defined by large offset strain.In the present work, the magnetron sputtering technique was used to prepare new catalysts of formic acid electrooxidation based on TiO2 nanotubes decorated with Pt (platinum), Pd (palladium) or Pd + Pt nanoparticles. TiO2 nanotubes (TiO2 NTs) with strictly defined geometry were produced by anodization of Ti foil and Ti mesh in a mixture of glycerol and water with ammonium fluoride electrolyte. The above mentioned catalytically active metal nanoparticles (NPs) were located mainly on the top of the TiO2 NTs, forming 'rings' and agglomerates. A part of metal nanoparticles decorated also TiO2 NTs walls, thus providing sufficient electronic conductivity for electron transportation between the metal nanoparticle rings and Ti current collector. The electrocatalytic activity of the TiO2 NTs/Ti foil, decorated by Pt, Pd and/or Pd + Pt NPs was investigated by cyclic voltammetry (CV) and new Pd/TiO2 NTs/Ti mesh catalyst was additionally tested in a direct formic acid fuel cell (DFAFC). The results so obtained were compared with commercial catalyst-Pd/Vulcan. CV tests have shown for carbon supported catalysts, that the activity of TiO2 NTs decorated with Pd was considerably higher than that one decorated with Pt. Moreover, for TiO2 NTs supported Pd catalyst specific activity (per mg of metal) was higher than that for well dispersed carbon supported commercial catalyst. The tests at DFAFC have revealed also that the maximum of specific power for 0.2 Pd/TiO2 catalyst was 70% higher than that of the commercial one, Pd/Vulcan. Morphological features, and/or peculiarities, as well as surface composition of the resulting catalysts have been studied by scanning electron microscopy (SEM), scanning transmission electron microscopy (STEM), and chemical surface analytical methods (X-ray photoelectron spectroscopy-XPS; Auger electron spectroscopy-AES).To succeed in the design and optimization of liquid-assisted processes such as reactive infiltration for the fabrication of tailored refractory SiC/ZrSi2 composites, the interfacial phenomena that occur when Si-rich Si-Zr alloys are in contact with glassy carbon (GC) were investigated for the first time by the sessile drop method at T = 1450 °C. Specifically, two different Si-rich Si-Zr alloys were selected, and the obtained results in terms of wettability, spreading kinetics, reactivity, and developed interface microstructures were compared with experimental observations that were previously obtained for the liquid Si-rich, Si-Zr, near-eutectic composition (i.e., Si-10 at.%Zr) that was processed under the same operating conditions. The increase of the Si content only weakly affected the overall phenomena that were observed at the interface. From the practical point of view, this means that even Si-Zr alloys with a higher Si content, with respect to the near eutectic alloy, may be potentially used as infiltrant materials.Background Single-agent capecitabine (C) is a moderately effective chemotherapeutic compound in the treatment of patients with HER2-negative metastatic breast cancer (mBC). The capecitabine-vinorelbine (CV) combination is also used due to a good tolerability profile, but no studies have demonstrated its superiority over single-agent C. Methods We conducted a retrospective analysis to compare overall response rate (ORR), progression-free survival (PFS), overall survival (OS) and incidence of adverse events (AEs) in patients with HER2-negative mBC treated with CV vs. single-agent C. Results Out of 290 patients included in this study, 127 (43.8%) received single-agent C, while 163 (56.2%) patients were treated with CV. Median PFS was similar in patients treated with single-agent C or CV, while CV was associated with significantly longer OS in patients with hormone receptor-positive (HR+) BC. This OS advantage was confirmed at multivariable analysis also after propensity score-based matching of patients according to relevant clinical or tumor characteristics. When compared with single-agent C, CV was associated with higher incidence of G3/G4 and any-grade nausea/vomiting, diarrhea and increased transaminases. Conclusions While prospective studies are needed to confirm our findings, the potential OS advantage of CV over single-agent C in HR+ mBC patients must be weighed against a significantly higher incidence of AEs.Exocrine pancreatic ductal adenocarcinoma, simply referred to as pancreatic cancer (PC) has the worst prognosis of any malignancy. Despite recent advances in the use of adjuvant chemotherapy in PC, the prognosis remains poor, with fewer than 8% of patients being alive at 5 years after diagnosis. The prevalence of PC has steadily increased over the past decades, and it is projected to become the second-leading cause of cancer-related death by 2030. In this context, optimizing and integrating supportive care is important to improve quality of life and survival. Venous thromboembolism (VTE) is a common but preventable complication in PC patients. VTE occurs in one out of five PC patients and is associated with significantly reduced progression-free survival and overall survival. The appropriate use of primary thromboprophylaxis can drastically and safely reduce the rates of VTE in PC patients as shown from subgroup analysis of non-PC targeted placebo-controlled randomized trials of cancer patients and from two dedicated controlled randomized trials in locally advanced PC patients receiving chemotherapy.